Amiodarone Side Effects 

Homepage: EMNote.org
Amiodarone Side Effects:
Amiodarone is a potent antiarrhythmic agent that is used to treat ventricular arrhythmias and atrial fibrillation.
However, its administration in certain conditions can be catastrophic.
Here are six conditions in which healthcare providers should avoid administering amiodarone or use with extreme caution:
1. Arrhythmias secondary to prolonged QT interval:
Amiodarone can prolong the QT interval, which can lead to torsades de pointes, a life-threatening arrhythmia.
2. Atrial fibrillation associated with left atrial thrombus or A-fib with unknown onset:
Amiodarone treatment is associated with an increased risk of stroke in patients with A-fib, which may be the result of thrombus dislodgement and embolization.
3. Atrial fibrillation in preexcitation or WPW syndrome:
Amiodarone can cause a paradoxical increase in conduction through the accessory pathway, leading to ventricular fibrillation.
4. Arrhythmias due to digoxin toxicity:
Digoxin levels increase significantly after coadministration with amiodarone.
This increase occurs because of the inhibition of digoxin secretion from renal tubules and the inhibition of the P-glycoprotein membrane transporter system.
5. Atrial fibrillation in hyperthyroidism:
Thyroid toxicity is the most common complication that requires intervention. Amiodarone can cause hypothyroidism or exacerbate hyperthyroidism[3]. Hyperthyroidism may result from an excess of iodine or acute thyroiditis. Hypothyroidism is two to four times more common than hyperthyroidism.
6. VT mimics due to hyperkalemia, Na-channel blocker toxicity, and accelerated idioventricular rhythm:
Amiodarone can worsen wide complex tachycardias mimicking ventricular tachycardia such as severe hyperkalemia, sodium-channel blocker toxicity, and AIVR.
Amiodarone is associated with several serious side effects that require careful monitoring and management.
Pulmonary toxicity.
The most serious potential adverse effect of amiodarone therapy is pulmonary toxicity, which may result from direct drug-induced phospholipidosis or immune-mediated hypersensitivity.
The most common clinical presentation is subacute cough and progressive dyspnea, with associated patchy interstitial infiltrates on chest radiographs and reduced diffusing capacity on pulmonary function tests.
A much less common presentation is adult respiratory distress syndrome (ARDS).
Hyperthyroidism.
Amiodarone can cause hyperthyroidism by inhibiting the conversion of thyroxine (T4) to triiodothyronine (T3) in peripheral tissues.
This can lead to symptoms such as weight loss, palpitations, and tremors.
Hypothyroidism.
Amiodarone can also cause hypothyroidism by causing thyroiditis or by inhibiting the release of thyroid hormones.
This can lead to symptoms such as fatigue, weight gain, and cold intolerance.
Liver toxicity.
Amiodarone can cause liver toxicity, which is usually mild and evidenced only by abnormal liver enzymes
However, in rare cases, it can cause severe liver injury, including acute liver failure.
Optic neuropathy.
Amiodarone can cause optic neuropathy, which is a rare but serious side effect that can lead to vision loss.
Proarrhythmia.
Amiodarone can cause proarrhythmia, which is the development of new or worsened arrhythmias.
This can occur due to the drug's effects on cardiac repolarization.
Bradycardia.
Amiodarone can cause bradycardia due to the drug's effects on the sinus node.
Amiodarone is also associated with several minor side effects:
Nausea, anorexia, and constipation.
Corneal microdeposits.
Photosensitivity.
Blue discoloration of skin.
It is important to note that the frequency of most adverse effects is related to the total amiodarone exposure (i.e., dosage and duration of treatment).
Therefore, physicians must use the lowest possible dosage of amiodarone and, if possible, discontinue treatment if adverse effects occur.
If any of these minor side effects persist or become bothersome, patients should consult their healthcare provider.
Some of the drugs that commonly interact with amiodarone include:
Digoxin:
Amiodarone can increase the serum concentration of digoxin, which can lead to digoxin toxicity.
Warfarin (Coumadin).
Simvastatin (Zocor).
Sildenafil (Viagra).
Cyclosporine (Sandimmune).
Antiarrhythmic.
Quinolones.
Antidepressants.
In conclusion, it is important for healthcare providers to know that amiodarone has many side effects, and there is also the potential for interacting adversely with other medications.
Patients receiving amiodarone should chronically have baseline testing done to facilitate future monitoring of hepatic, thyroid, pulmonary, and ophthalmologic toxicity.
Patients on warfarin will also need close monitoring of their INR.
All providers, including physicians, nurses, and pharmacists, should be aware of the risks associated with amiodarone administration and take appropriate precautions to ensure patient safety.